Physiological and pathological responses to hypoxia

American Journal of Pathology

Volumn 164, Issue 6, 2004, Pages 1875-1882

  Michiels, Carine ^a,b  

^a UNIVERSITY OF NAMUR   (Belgium)

^b FNRS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; DNA; ERYTHROPOIETIN; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; OXYGEN; POTASSIUM ION; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RNA; VASCULOTROPIN;

ADAPTATION; ANGIOGENESIS; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CAROTID BODY CHEMORECEPTOR; CELL DEATH; CELL METABOLISM; CEREBROVASCULAR DISEASE; CHEMORECEPTOR; GENE EXPRESSION REGULATION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; HYPOXIA; ISCHEMIC HEART DISEASE; METABOLIC REGULATION; MITOCHONDRION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; VASCULAR SMOOTH MUSCLE;

EID: 2442676752     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63747-9     Document Type: Review

References (62)

1. Yuan XJ, Tod ML, Rubin LJ, Blaustein MP: Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. Am J Physiol 1990, 259:H281-H289
2. Post JM, Hume JR, Archer SL, Weir EK: Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol 1992, 262:C882-C890
3. Archer SL, Weir EK, Reeve HL, Michelakis E: Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation. Adv Exp Med Biol 2000, 475:219-240
4. Dart C, Standen NB: Activation of ATP-dependent K+ channels by hypoxia in smooth muscle cells isolated from the pig coronary artery. J Physiol 1995, 483:29-39
5. Lopez-Barneo J, Pardal R, Ortega-Saenz P: Cellular mechanism of oxygen sensing. Annu Rev Physiol 2001, 63:259-287
6. Peers C, Kemp PJ: Acute oxygen sensing: diverse but convergent mechanisms in airway and arterial chemoreceptors. Respir Res 2001, 2:145-149
7. O'Kelly I, Lewis A, Peers C, Kemp PJ: O(2) sensing by airway chemoreceptor-derived cells: protein kinase c activation reveals functional evidence for involvement of NADPH oxidase. J Biol Chem 2000, 275:7684-7692
8. Kemp PJ, Lewis A, Hartness ME, Searle GJ, Miller P, O'Kelly I, Peers C: Airway chemotransduction: from oxygen sensor to cellular effector. Am J Respir Crit Care Med 2002, 166:S17-S24
9. Fu XW, Wang D, Nurse CA, Dinauer MC, Cutz E: NADPH oxidase is an O2 sensor in airway chemoreceptors: evidence from K+ current modulation in wild-type and oxidase-deficient mice. Proc Natl Acad Sci USA 2000, 97:4374-4379
10. Prabhakar NR, Overholt JL: Cellular mechanisms of oxygen sensing at the carotid body: heme proteins and ion channels. Respir Physiol 2000, 122:209-221
11. Hochachka PW: Defense strategies against hypoxia and hypothermia, Science 1986, 231:234-241
12. Gnaiger E: Bioenergetics at low oxygen: dependence of respiration and phosphorylation on oxygen and adenosine diphosphate supply. Respir Physiol 2001, 128:277-297
13. Borutaite V, Mildaziene V, Brown GC, Brand MD: Control and kinetic analysis of ischemia-damaged heart mitochondria: which parts of the oxidative phosphorylation system are affected by ischemia? Biochim Biophys Acta 1995, 1272:154-158
14. Boutilier RG: Mechanisms of cell survival in hypoxia and hypothermia. J Exp Biol 2001, 204:3171-3181
15. Rolfe DF, Brown GC: Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997, 77:731-758
16. Tinton S, Tran-Nguyen QN, Buc-Calderon P: Role of protein-phosphorylation events in the anoxia signal-transduction pathway leading to the inhibition of total protein synthesis in isolated hepatocytes. Eur J Biochem 1997, 249:121-126
17. Buttgereit F, Brand MD: A hierarchy of ATP-consuming processes in mammalian cells. Biochem J 1995, 312:163-167
18. Ashram AM, Howell JJ, Simon MC: A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its target. J Biol Chem 2003, 278:29655-29660
19. Boutilier RG, St-Pierre J: Surviving hypoxia without really dying. Comp Biochem Physiol 2000, 126:481-490
20. Heuch G: Hibernating myocardium. Physiol Rev 1998, 78:1055-1085
21. 2 sensor. J Biol Chem 1998, 273:3320-3326
22. Hue L, Rider MH: Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. Biochem J 1987, 245:313-324
23. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, Hue L: Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 2000, 10:1247-1255
24. Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V, Caro J: Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene: its possible role in the Warburg effect. J Biol Chem 2002, 277:6183-6187
25. Ramaiah A, Hathaway JA, Atkinson DE: Adenylate as a metabolic regulator: effect on yeast phosphofructokinase kinetics. J Biol Chem 1964, 239:9619-9622
26. Carling D, Zammit VA, Hardie DG: A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett 1987, 223:217-222
27. Hardie DG, Hawley SA: AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 2001, 23:1112-1119
28. Hardie DG: Metabolic control: a new solution to an old problem. Curr Biol 2000, 10:R757-R759
29. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA: Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 1999, 24:22-25
30. Semenza GL: Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 2000, 1:159-162
31. Lang KJ, Kappel A, Goodall GJ: Hypoxia-inducible factor-1α mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell 2002, 13:1792-1801
32. 2 sensing. Science 2001, 292:464-468
33. 2-regulated prolyl hydroxylation. Science 2001, 292:468-472
34. Mottet D, Dumont V, Deccache Y, Demazy C, Ninane N, Raes M, Michiels C: Regulation of hypoxia-inducible factor-1α protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3β pathway in HepG2 cells. J Biol Chem 2003, 278:31277-31285
35. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Sernenza GL: Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000, 60:1541-1545
36. Minet E, Michel G, Mottet D, Raes M, Michiels C: Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radic Biol Med 2001, 31:847-855
37. Huang LE, Bunn HF: Hypoxia-inducible factor-1 and its biological relevance. J Biol Chem 2003, 278:19575-19578
38. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML: Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 2002, 295:858-861
39. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev 1998, 12:149-162
40. Ryan HE, Lo J, Johnson RS: HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998, 17:3005-3015
41. Kozak ZR, Abbott B, Hankinson O: ARNT-deficient mice and placental differentiation. Dev Biol 1997, 191:297-305
42. Biagas K: Hypoxic-ischemic brain injury: advancements in the understanding of mechanisms and potential avenues for therapy. Curr Opin Pediatr 1999, 11:223-228
43. Erecinska M, Silver IA: Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 2001, 128:263-276
44. Kloner RA, Jennings RB: Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 2001, 104:2981-2989
45. Braunwald E, Kloner RA: The stunned myocardium: prolonged, post-ischemic ventricular dysfunction. Circulation 1982, 66:1146-1149
46. Bolli R, Jeroudi MO, Patel BS, DuBose CM, Lai EK, Roberts R, McCay PB: Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 1989, 86:4695-4699
47. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395
48. Dachs GU, Tozer GM: Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer 2000, 36:1649-1660
49. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999, 15:551-578
50. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL: Expression of hypoxia-inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression. Cancer 2000, 88:2606-2618
51. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW: Overexpressior of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999, 59:5830-5835
52. Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P, Laderoute K, Johnson RS: Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol 2001, 21:3436-3444
53. Dewhirst MW, Klitzman B, Braun RD, Brizel DM, Haroon ZA, Secornb TW: Review of methods used to study oxygen transport at the microcirculatory level. Int J Cancer 2000, 90:237-255
54. Evans SM, Hahn S, Pook DR, Jenkins WT, Chalian AA, Zhang P, Stevens C, Weber R, Weinstein G, Benjamin I, Mirza N, Morgan M, Rubin S, McKenna WG, Lord EM, Koch CJ: Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res 2000, 60:2018-2024
55. Vukovic V, Haugland HK, Nicklee T, Morrison AJ, Hedley DW: Hypoxia-inducible factor-1α is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res 2001, 61:7394-7398
56. Vordermark D, Brown JM: Evaluation of hypoxia-inducible factor-1α (HIF-1α) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies. Int J Radiat Oncol Biol Phys 2003, 56:1184-1193
57. Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Hofland I, Hoebers FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, Balm AJ, van Velthuysen ML, Delaere P, Sciot R, Begg AC: HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. Int J Radiat Oncol Biol Phys 2002, 54:1537-1549
58. Olive PL, Aquino-Parsons C, MacPhail SH, Liao SY, Raleigh JA, Lerman MI, Stanbridge EJ: Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 2001, 61:8924-8929
59. Hoskin PJ, Sibtain A, Daley FM, Wilson GD: GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularly and proliferation as predictors of outcome of ARCON. Br J Cancer 2003, 89:1290-1297
60. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W: Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000, 156:965-976
61. Rosenberger C, Griethe W, Gruber G, Wiesener M, Frei U, Bachmann S, Eckardt KU: Cellular responses to hypoxia after renal segmental infarction. Kidney Int 2003, 64:874-886
62. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3:721-732